Biophytis SA Sponsored ADR (BPTSY) vs Propanc Biopharma Inc (PPCB)

Biophytis SA Sponsored ADR and Propanc Biopharma Inc are both Biotechnology companies. Biophytis SA Sponsored ADR is the larger, with a market value of $2.4M against $2.1M — 1.1× the size. Biophytis SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Propanc Biopharma Inc trades at 0.0×. Across the 9 metrics below, Biophytis SA Sponsored ADR leads on 5 and Propanc Biopharma Inc on 4.

Valuation

Metric BPTSY PPCB Biotechnology median
P/E n/m 0.00 7.88
P/S n/m n/m 11.47
P/B n/m 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (126.92%) 257,474.29% (28.84%)
Free cash flow yield (2,235.65%) (739.21%) (23.03%)

Profitability

Metric BPTSY PPCB Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (138.20%) (57.72%)
Return on assets 0.00% (104.68%) (49.22%)
Return on invested capital 0.00% (116.59%) 0.00%

Growth

Metric BPTSY PPCB Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (59.60%) 98.81% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTSY PPCB Biotechnology median
Debt to equity (0.99) 0.05 0.00
Current ratio 0.35 2.37 4.73
Net debt to EBITDA (1.24) (0.01) 0.96

Dividend

Metric BPTSY PPCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BPTSY PPCB Biotechnology median
Market cap 2.36m 2.14m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack